We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Nathaniel West - Senior Scientist, Cancer Immunology

Nathaniel West

Senior Scientist, Cancer Immunology

5
Years at Genentech
2
Awards & Honors

I joined the Cancer Immunology Department at Genentech in 2017 after completing post-doctoral work at the University of Oxford, UK, where I studied the inflammatory processes that underlie inflammatory bowel disease and colorectal cancer. Prior to this, I trained in immune-oncology at the British Columbia Cancer Agency, with a focus on inflammation in breast cancer.

At Genentech, my team studies the complex mechanisms of communication that exist between immune and non-immune cells in tumors, with the goal of developing novel immunotherapies for cancer.

Featured Publication

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

Nature Medicine 23: 579–89.

2017. West NR, Hegazy AN, Owens BMJ, Bullers SJ, Linggi B, Buonocore S, Coccia M, Görtz D, This S, Stockenhuber K, Pott J, Friedrich M, Ryzhakov G, Baribaud F, Brodmerkel C, Cieluch C, Rahman N, Müller-Newen G, Owens R, Kühl A, Maloy KJ, Plevy SE, Oxford IBD Cohort Investigators, Keshav S, Travis SPL, and Powrie F.